期刊文献+

细胞外信号调节激酶在TPPB促进PC12产生可溶性淀粉样前体蛋白中的作用 被引量:2

Involvement of extracellular signal regulated kinase in the regulation of amyloid precursor protein processing in PC12 cells by TPPB
下载PDF
导出
摘要 目的:观察在蛋白激酶C(PKC)激动剂TPPB促进可溶性淀粉样前体蛋白(sAPPα)释放过程中参与的信号转导通路。方法:以1μmol/L的TPPB作用于PC12细胞3h,同时加入信号转导通路的抑制剂,Western印迹法检测上清液内sAPPα的含量和细胞外信号调节激酶(p42/44MAPK)及磷酸化的p42/44MAPK的表达。结果:1μmol/L的TPPB作用于PC12细胞3h可以显著增加上清液内sAPPα的含量,细胞外信号调节激酶抑制剂U0126、c-Jun氨基末端激酶抑制剂SP600125和蛋白酪氨酸激酶抑制剂genistein可以部分消除此作用;而p38MAPK抑制剂SB203580对sAPPα的含量无显著影响。1μmol/L的TPPB可以使磷酸化的p42/44MAPK表达增加,而对总的p42/44MAPK无显著影响。结论:细胞外信号调节激酶、c-Jun氨基末端激酶和蛋白酪氨酸激酶可能参与TPPB促进sAPPα生成的过程。 AIM: To explore the signal transduction pathways involved in the regulation of amyloid precursor protein (APP) processing by protein kinase C (PKC) activator TPPB. METHODS: PC12 cells were treated with TPPB ( PKC activator) for 3 h and various signal transduction inhibitors were added to the conditioned medium to investigate their effects on α - secretase form of soluble amyloid precursor protein (sAPPα) secretion after TPPB treatment via Western blotting. Extracellular signal regulated kinase ( ERK, p42/44MAPK) and phospho - p42/44MAPK were also measured after TPPB treatment. RESULTS: TPPB (1μmol/L) significantly increased sAPPα secretion as compared with control group. The increase in sAPPα secretion by TPPB was partially blocked by ERK inhibitor U0126, c - Jun N - terminal kinase (JNK) inhibitor SP600125 and protein tyrosine kinase (PTK) inhibitor genistein, but not by p38MAPK inhibitor SB203580. TPPB ( 1μmol/L) increased the expression of phospho - p42/44MAPK without altering total p42/44MAPK levels. CONCLUSION: ERK, JNK and PTK may be involved in the regulation of APP processing by TPPB.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2008年第1期24-27,共4页 Chinese Journal of Pathophysiology
基金 国家重点基础研究发展计划(973计划)资助项目(No.2006CB500700)
关键词 蛋白激酶C 淀粉样前体蛋白 有丝分裂素激活蛋白激酶类 阿尔茨海默病 Protein kinase C Amyloid precursor protein Mitogen- activated protein kinases Alzheimer disease
  • 相关文献

参考文献5

二级参考文献67

共引文献35

同被引文献19

  • 1杨玲玲,张静,崔云燕,胡晓燕,孔峰,崔行.以神经内肽酶为靶点筛选治疗阿尔茨海默症天然药物的实验研究[J].山东大学学报(医学版),2009,47(1):10-14. 被引量:6
  • 2孙丽文,唐孝威,胡应和.β淀粉样肽在阿尔茨海默症发病中的分子机制[J].生物化学与生物物理进展,2007,34(1):18-24. 被引量:10
  • 3Marr RA, Guan H, Rockenstein E, et al. Neprilysin regulates amyloid beta peptide levels [ J ]. J Mol Neurosci, 2004,22( 1 -2) :5 - 11.
  • 4Iwata N, Tsubuki S, Takaki Y, et al. Identification of the major A betal -42 -degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition [ J ]. Nat Med,2000, 6 (2) : 143 - 150.
  • 5Marr RA, Rockenstein E, Mukherjee A, et al. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice [J]. J Neurosci,2003, 23(6):1992- 1996.
  • 6Burgos - Ramos E, Hervas - Aguilar A, Aguado - Llera D, et al. Somatostatin and Alzheimer's disease [ J ]. Mol Cell Endocrino1,2008,286 ( 1 - 2 ) : 104 - 111.
  • 7Andersen JM, Myhre O, Fonnum F. Discussion of the role of the extracellular signal - regulated kinase - phospholipase A2 pathway in production of reactive oxygen species in Alzheimer's disease [ J ]. Neurochem Res, 2003, 28 (2) :319 -326.
  • 8Tuppo EE, Forman LJ. Free radical oxidative damage and Alzheimer's disease [ J ]. J Am Osteopath Assoc, 2001, 101(12 Suppl Pt 1):S11 -S15.
  • 9Iwata N, Saido TC. Amyloid - beta peptide metabolism and Alzheimer's disease [ J ]. Nippon Yakurigaku Zasshi, 2003,122(1) :5 -14.
  • 10Iwata N, Tsubuki S, Takaki Y, et al. Metabolic regula- tion of brain Aβby nep rilysin [ J]. Science, 2001, 292 (5521) : 1550 - 1552.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部